Table 2 Ranking of gene signatures.
Rank | Gene signature | Taxonomy terms |
|---|---|---|
1 | Verhaak et al., Haematologica, 2009, AML, NPM1 | NPM1 mutated |
2 | Verhaak et al., Haematologica, 2009, AML, NPM1 and FLT3-ITD | - |
3 | Verhaak et al., Haematologica, 2009, AML, NPM1 without FLT3-ITD | NPM1 mutated |
4 | Verhaak et al., Haematologica, 2009, AML, FLT3-ITD or FLT3-TKD | FLT3 |
5 | Alcalay et al., Blood, 2005, AML, NPM1 | NPM1 mutated |
6 | Verhaak et al., Haematologica, 2009, AML, FLT3-ITD | FLT3-ITD, FLT3 |
7 | Alcalay et al., Blood, 2005, AML, NPM1, | NPM1 mutated |
8 | Valk et al., N Engl J Med, 2004, Classification of AML subtypes | - |
9 | Ross et al., Blood, 2004, AML and ALL, t(11q23)/MLL | t(11q23)/MLL, Chrom. aberration |
10 | Mullighan et al., Leukemia, 2007, AML, NPM1 | NPM1 mutated |
11 | Mullighan et al., Leukemia, 2007, AML, NPM1 | NPM1 mutated |
12 | Verhaak et al., Haematologica, 2009, AML, del(7q) | del(7q) |
13 | Mullighan et al., Leukemia, 2007, AML, NPM1 | NPM1 mutated |
14 | Verhaak et al., Haematologica, 2009, AML, t(15;17) | t(15;17), Chrom. aberration |
15 | Marcucci et al., J Clin Oncol, 2008, AML, CEBPA | CEBPA |
16 | Stirewalt et al., Genes Chromosomes Cancer, 2008, AML | AML, Leukemia |
17 | Valk et al., N Engl J Med, 2004, AML, CEBPA | CEBPA |
18 | Ross et al., Blood, 2003, B-ALL, t(11q23)/MLL | - |
19 | van Delft et al., Br J Haematol, 2005, AML, t(11q23)/MLL | t(11q23)/MLL, Chrom. aberration |
20 | Valk et al., N Engl J Med, 2004, AML, cluster without predominant characteristics | - |
21 | Verhaak et al., Blood, 2005, AML, NPM1 | NPM1 mutated |
22 | Langer et al., Blood, 2008, AML, BAALC | - |
23 | van Delft et al., Br J Haematol, 2005, AML, t(11q23)/MLL | t(11q23)/MLL, Chrom. aberration |
24 | Armstrong et al., Nat Genet, 2002, ALL, t(11q23)/MLL | t(11q23)/MLL, Chrom. aberration |
25 | Valk et al., N Engl J Med, 2004, AML, mostly EVI1 | - |
â‹® | â‹® | â‹® |